EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. center

Saar Anis, Shannon Shaffer

Clinical Parkinsonism & Related Disorders · 2026 · 15 · 100492

DOI: 10.1016/j.prdoa.2026.100492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Parkinsonism & Related Disorders, 2026. Verfasst von Saar Anis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research, American Parkinson's Disease Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Advanced therapiesDeep brain stimulationFoscarbidopaFoslevodopaImplementationParkinson's diseaseSubcutaneous infusion

Autor:innen und Institutionen

  • Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States.

Förderung

  • Michael J. Fox Foundation for Parkinson's Research
  • American Parkinson's Disease Foundation

Zitieren

APA

Anis, S., & Shaffer, S. (2026). Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. center. Clinical Parkinsonism & Related Disorders, 15, 100492. https://doi.org/10.1016/j.prdoa.2026.100492

Vancouver

Anis S, Shaffer S. Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. center. Clinical Parkinsonism & Related Disorders. 2026;15:100492. doi:10.1016/j.prdoa.2026.100492

BibTeX
@article{Anis2026,
  author = {Anis, Saar and Shaffer, Shannon},
  title = {Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. center},
  journal = {Clinical Parkinsonism & Related Disorders},
  year = {2026},
  volume = {15},
  pages = {100492},
  doi = {10.1016/j.prdoa.2026.100492}
}
Kostenlos starten →